Metabolic Syndrome: Diagnostic Criteria, Staging, and Prevention Strategies in Chinese Patients
Metabolic syndrome is a condition characterized by the accumulation of multiple diseases such as hypertension, hyperglycemia, hyperlipidemia, and obesity. Its prominent manifestations include overweight, obesity, hypertension, and arteriosclerosis. A common pathogenesis is insulin resistance. Currently, the prevalence of metabolic syndrome in people over 20 years of age is 10%–14%. In 2004, the Chinese Diabetes Society proposed diagnostic criteria suitable for the Chinese population.
Table 10 Diagnostic Criteria for Metabolic Syndrome | Item | Criteria | | :--- | :--- | | Obesity | BMI ≥ 25 | | Hypertension | SBP ≥ 140 mmHg, DBP ≥ 90 mmHg, or already diagnosed and receiving treatment | | Hyperlipidemia | TG ≥ 150 mg/dl, HDL-C < 35 mg/dl for men, HDL-C < 39 mg/dl for women | | Hyperglycemia | FPG ≥ 110 mg/dl, 2h PG ≥ 140 mg/dl, or already diagnosed and receiving treatment | | Diagnosis | A diagnosis can be made if 3 or all 4 of the above criteria are met.
Currently, there is a tendency to include hyperuricemia in this category, forming the "six highs and one lipid": high weight (obesity), high blood pressure, high blood lipids, hyperuricemia, hyperinsulinemia, hyperglycemia, and fatty liver. Central obesity is a risk factor for metabolic syndrome. Waist-to-hip ratio (WHR) = waist circumference/hip circumference. Central obesity criteria: men >0.9, women >0.85. Prevention staging strategies: ① Early stage: Focus on prevention: Control various risk factors. The primary treatment is to adjust lifestyle habits, lose weight, and exercise. The main goals are to lower LDL-C, blood sugar, and blood pressure. ② Mid-stage: Focus on treatment: Often, related organ damage has occurred. Ventricular thickening, abnormal kidney function. Medications required include antihypertensive drugs, lipid-lowering drugs, and insulin sensitizers. Reversal is possible. ③ Late stage: Focus on rescue: Organ dysfunction or irreversible damage has occurred (such as stroke, myocardial infarction, heart and kidney failure). The main focus is on symptomatic treatment to save lives as much as possible. BMI (Body Mass Index) is used to determine whether a person's weight is appropriate: BMI = actual weight (kg) ÷ height squared (m²). A BMI between 18.5 and 23.9 is considered an appropriate weight. Overweight and obesity are independent risk factors for coronary heart disease and stroke.
Traditional Chinese Medicine for Hypertension (IV): Blood Pressure Tablets and Dizziness-Relieving Granules
This article continues to introduce traditional Chinese medicine preparations for hypertension, including Xueyaping tablets, Jiangya Bifeng tablets, Luohuang Jiangya tablets, Xinmaitong tablets, Luobuma Jiangya tablets, Duzhong Pingya tablets, Zhongfeng tablets, Yufeng Ningxin tablets, Gou Teng Zongjian tablets, Maijun'an tablets, Xinxuening tablets, Tianma Mihuanjun tablets, Xinkeshu tablets,...
2026-04-22Traditional Chinese Medicine for Hypertension (Part 5) and Selected Decoction Formulas (Part 1)
This article comprises two parts: traditional Chinese medicine preparations for hypertension (Yangxue Qingnao Granules, Xuanyun Ning Granules, Qingnao Jiangya Capsules, Yangyin Jiangya Capsules, Qinggan Jiangya Capsules, Quantianma Capsules, Blood Pressure Lowering Syrup, Qingre Mingmu Tea, Blood Pressure Lowering Tea Bags, Qiju Dihuang Pills); and decoctions for hypertension (Tianma Gouteng...
2026-05-12Selected Formulas for Hypertension Decoctions (Part 3): Medicated Pillow Therapy and Body Acupuncture Therapy
This article continues to include herbal formulas for hypertension (Buzhong Yiqi Tang, Danggui Longhui Wan, Xiexin Tang, Wuzhuyu Tang, Yiqi Congming Tang, Linggui Zhugan Tang, Lingjiao Gouteng Tang, Zexie Tang, Danggui Shaoyao San), as well as physical therapies for hypertension (medicated pillow therapy, body acupuncture therapy). Each formula details its ingredients, efficacy, indications,...
2026-05-13